![]() |
|
|
Vol. 28, Issue 9, 1112-1120, September 2000
Département de Pharmacologie, Faculté de
Médecine, Université de Montréal Montréal,
Québec, Canada
Serum of rabbits with a turpentine-induced acute inflammatory
reaction (RSINFLA) and serum of humans with a viral
infection (HSINF) were previously shown to diminish hepatic
cytochrome P450 (P450) content and activity. To document the role of
reactive oxygen intermediates in the serum-mediated decrease in P450
content and activity, hepatocytes of rabbits with an acute inflammatory reaction (HINFLA) were incubated with RSINFLA
and HSINF for 4 h, and total P450 content (spectrally
measurable P450), P450 activity (assessed by estimating the formation
of theophylline metabolites), and amount of CYP1A1, CYP1A2, and CYP3A6
proteins were measured. RSINFLA or HSINF
decreased P450 content and activity without affecting the amount of
CYP1A1 and -1A2 HINFLA. Exposure of HCONT or
HINFLA to hydrogen peroxide (0.01-1.0 mM) and sodium
nitroprusside (0.01-1.0 mM) produced a dose-dependent decrease in P450
content and in the formation of theophylline metabolites without
modifying the amount of CYP1A1 and CYP1A2, whereas lipid peroxidation
increased. Incubation of L-NAME (0.05-1.0 mM),
dimethylthiourea (6.25-50 mM), or N-acetylcysteine
(0.01-1.0 mM) with HINFLA partially prevented the decrease
in P450 content and activity and the increased lipid peroxidation
induced by RSINFLA and HSINF. On the other
hand, 3-amino-1,2,4-triazole (10-100 mM) or diethyldithiocarbamate
(1.0-10 mM) potentiated RSINFLA- and
HSINF-mediated decreases in P450 content and activity and
the increase in lipid peroxidation, without affecting the amount of
CYP1A1 or -1A2;
DL-buthionine-(S,R)-sulfoximine (2.5-25 mM) potentiated only the inhibition of 1,3-dimethyluric acid
formation. It is concluded that reactive oxygen intermediates are
implicated in the decrease of HINFLA P450 content and
activity induced by 4 h of exposure to RSINFLA or
HSINF.
This article has been cited by other articles:
![]() |
O. Kourylko, C. Fradette, M. Arcand, and P. du Souich MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6 Drug Metab. Dispos., January 1, 2006; 34(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miura, J. J. Bosnjak, G. Ning, T. Saito, M. Miura, and D. D. Gutterman Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles Circ. Res., February 7, 2003; 92 (2): e31 - e40. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Bleau, C. Fradette, A. O. S. El-Kadi, M.-C. Cote, and P. du Souich Cytochrome P450 Down-Regulation by Serum from Humans with a Viral Infection and from Rabbits with an Inflammatory Reaction Drug Metab. Dispos., July 1, 2001; 29(7): 1007 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points Carcinogenesis, July 1, 2001; 22(7): 999 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Morgan Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How? Drug Metab. Dispos., March 1, 2001; 29(3): 207 - 212. [Abstract] [Full Text] |
||||